
Placental Growth Factor and the Risk of Adverse Neonatal and Maternal Outcomes
Author(s) -
Jacqueline G. Parchem,
Clifton O. Brock,
Han-Yang Chen,
Raghu Kalluri,
John R. Barton,
Baha M. Sibai,
Preeclampsia Triage by Rapid Assay Trial Investigators
Publication year - 2020
Publication title -
obstetrics and gynecology (new york. 1953. online)/obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.664
H-Index - 220
eISSN - 1873-233X
pISSN - 0029-7844
DOI - 10.1097/aog.0000000000003694
Subject(s) - medicine , preeclampsia , placental growth factor , obstetrics , gestation , pregnancy , prospective cohort study , poisson regression , relative risk , observational study , cohort study , confidence interval , population , genetics , environmental health , vascular endothelial growth factor , vegf receptors , biology
To evaluate whether abnormal plasma placental growth factor (PlGF) level is associated with adverse neonatal and maternal outcomes.